Black Diamond Therapeutics Inc

BDTXNASDAQ · USD
1.95USD+0.02 (+0.78%)
235

Black Diamond Therapeutics Inc (BDTX) Implied Volatility Current

BDTX implied volatility is 117%. IV Rank is 11%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking BDTX implied volatility helps you identify when options premiums on Black Diamond Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Black Diamond Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when BDTX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Black Diamond Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BDTX, tracking metrics like BDTX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BDTX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations.

It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BDTX implied volatility sits today versus where it has been. Our scanner ranks Black Diamond Therapeutics Inc implied volatility against its historical range, surfaces extremes in BDTX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Black Diamond Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
11.11%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)117.15%

IV Rank11.11%

Historical Volatility (30d)52.39%

IV - HV+64.76%

As of September 17, 2026

Trade options with IV on your side

Track BDTX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial